CD33 and animal viral hepatitis: Taken together, these findings clarify the interactions between CD33 and chronic HBV and HCV in determining cognitive trajectories, and provide promising therapeutic avenues to combat neurocognitive dysfunctions arising from chronic viral hepatitis or broader neurodegenerative challenges.